Detection Of Specific Genomic Alterations In ctDNA Appeared To Be Linked To Poorer Outcomes Among Women With Metastatic Breast Cancer, Research Finds

Healio (11/7, Shinkle) reported, “The detection of specific genomic alterations in circulating tumor DNA appeared linked to poorer outcomes among women with metastatic breast cancer, according to study results.” These “findings suggest circulating tumor DNA (ctDNA) could be a prognostic biomarker in this setting, researchers concluded.” The findings were published in JAMA Network Open.